Got Cellulite? You Need to Try EmTone

EmTone for Cellulite Virginia

If you’re a Virginia resident and you’ve got cellulite and want to achieve smoother, firmer skin, EmTone can help.

The revolutionary technology harnesses the power of thermal and mechanical energy to remodel tissue in a way that is not possible with other stand-alone cellulite treatments.

Continue reading to discover all of the reasons why you need to try EmTone.

What Is EmTone?

EmTone is an FDA-approved non-invasive treatment designed to firm skin and reduce the appearance of cellulite on the thighs, buttocks, abdomen, and arms.

It is uniquely engineered to target the five underlying causes of cellulite–enlarged fat chambers, damaged collagen fibers, loss of skin elasticity, poor blood flow, and metabolic waste accumulation–to produce dramatic improvement in skin tone, texture, and contours.

How Does EmTone Reduce Cellulite?

EmTone applies both thermal and mechanical energy to address the major causes of cellulite formation.

This includes: 

Why Choose EmTone for Cellulite?

Thanks to its patented technology, EmTone produces a synergistic effect that cannot be achieved with stand-alone modalities.

As a result, EmTone is:

It also boasts a 90 percent patient satisfaction score!

Does EmTone Hurt?

Most patients find EmTone to be a quick, easy, and painless process.

In fact, the treatment feels very similar to a massage.

How Many EmTone Treatments Are Recommended?

A series of six-to-eight treatments, spaced a week apart, is recommended to achieve optimal cellulite reduction and firming, 

Is There Any Downtime After EmTone?

One of the key benefits of EmTone is that it avoids any downtime or disruption to your normal routine.

As such, patients are free to resume all usual activities immediately after treatment.

Want to Learn More About EmTone Cellulite Treatment?

For additional information about EmTone for cellulite reduction, please call our office today to schedule a comprehensive consultation with board-certified dermatologist Dr. Nicole Hayre.